ASHP Injectable Drug Information August 2024 Update

This update contains 4 new monographs, 54 revised monographs and 4 new MedWatch
alerts.

New monographs: Amivantamab-vmjw; Cefepime Hydrochloride-Enmetazobactam;
Panitumumab; Vedolizumab.

Revised monographs: Acetaminophen; Acyclovir Sodium; Albumin Human; Aminocaproic
Acid; Amiodarone Hydrochloride; Amoxicillin Sodium; Ampicillin Sodium; ASHP Injectable
Drug Information Users Guide; ASHP Injectable Drug Information References; Caffeine
Citrate; Calcitriol; Calcium Gluconate; Carmustine; Cefotaxime Sodium; Cetuximab;
Cloxacillin Sodium; DOBUTamine Hydrochloride; DOPamine Hydrochloride; EPINEPHrine
Hydrochloride; Ethacrynate Sodium; Fat Emulsion, Intravenous; FentaNYL Citrate;
Flumazenil; Fluorouracil; Gentamicin Sulfate; Glycopyrrolate; Heparin Sodium; Ibuprofen;
Ibuprofen Lysinate; Indomethacin Sodium Trihydrate; Insulin; Iodixanol; Iohexol; Iopamidol;
Meropenem; Methocarbamol; MetroNIDAZOLE; Midazolam Hydrochloride; Morphine
Sulfate; Nafcillin Sodium; Norepinephrine Bitartrate; PEMEtrexed Disodium; Penicillin G
Sodium; PENTobarbital Sodium; Pentostatin; PHENobarbital Sodium; Phentolamine
Mesylate; Piperacillin Sodium-Tazobactam Sodium; Sodium Bicarbonate; Succinylcholine
Chloride; Tirofiban Hydrochloride; Topotecan Hydrochloride; Vancomycin Hydrochloride;
Vecuronium Bromide.

New MedWatch alerts on the following monographs: Buprenorphine Hydrochloride;
DOCEtaxel; Labetalol Hydrochloride; Methocarbamol.

Removed MedWatch alerts on the following monographs: Bleomycin Sulfate; Lidocaine
Hydrochloride; Midazolam Hydrochloride.